Mogamulizumab-kpkc Intravenous and Pulmicort Nebuamp
Determining the interaction of Mogamulizumab-kpkc Intravenous and Pulmicort Nebuamp and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: budesonide
Brand name: Entocort EC, Uceris, Pulmicort Flexhaler, Pulmicort Respules
Synonyms: Pulmicort Nebuamp (Inhalation)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Pulmicort Oral
- Mogamulizumab-kpkc Intravenous-Pulmicort Respules
- Mogamulizumab-kpkc Intravenous-Pulmicort Spacer
- Mogamulizumab-kpkc Intravenous-Pulmicort Turbuhaler
- Mogamulizumab-kpkc Intravenous-PulmoSal
- Mogamulizumab-kpkc Intravenous-Pulmozyme
- Pulmicort Nebuamp-Molindone
- Pulmicort Nebuamp-Mometasone (Oral Inhalation)
- Pulmicort Nebuamp-Mometasone and Formoterol
- Pulmicort Nebuamp-Mometasone and formoterol Inhalation
- Pulmicort Nebuamp-Mometasone Cream
- Pulmicort Nebuamp-Mometasone Furoate